SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Wells Fargo 2015 Healthcare Conference in Boston, MA, on September 10, 2015.
|Wells Fargo 2015 Healthcare Conference|
|Date:||Thursday, September 10, 2015|
|Time:||8:35 am Eastern Time / 5:35 am Pacific Time|
|Location:||Boston, MA – Hyatt Regency, Room 2|
The presentation will be webcast live and archived for 30 days on Zogenix’s Investor Relations website at ir.zogenix.com.
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | Andrew@lifesciadvisors.com